WILLIAM COX: Open Payments
NPI 1902946858 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,679 in 190 payments from 27 companies in 2025. Trend: 2023 $4,731 · 2024 $3,913 · 2025 $3,679
Food & beverage: $3,679
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $468 |
| AstraZeneca Pharmaceuticals LP | 8 | $453 |
| Vanda Pharmaceuticals Inc. | 10 | $351 |
| ABBVIE INC. | 20 | $306 |
| Lilly USA, LLC | 21 | $266 |
| Astellas Pharma US Inc | 5 | $215 |
| Phathom Pharmaceuticals, Inc. | 11 | $185 |
| Sumitomo Pharma America, Inc. | 11 | $179 |
| PFIZER INC. | 11 | $157 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $150 |
Products named: FARXIGA, JARDIANCE, Veozah, HETLIOZ, Wegovy, VOQUEZNA, GEMTESA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
